Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Use of 18F FDG PET: A Systematic Review

被引:133
作者
Kwee, Robert M. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, NL-6202 AZ Maastricht, Netherlands
关键词
POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; ESOPHAGOGASTRIC JUNCTION; PATHOLOGICAL RESPONSE; PREOPERATIVE CHEMORADIATION; METABOLIC-ACTIVITY; INDUCTION CHEMORADIATION; COMPUTED-TOMOGRAPHY; FREE SURVIVAL;
D O I
10.1148/radiol.09091324
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To systematically review the accuracy of fluorine 18 ((18) F) fluorodeoxyglucose (FDG) positron emission tomography (PET) in the prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer. Materials and Methods: The MEDLINE and EMBASE databases were systematically searched for relevant studies. Methodologic quality of the included studies was assessed. Sensitivities and specificities of F-18 FDG PET in individual studies were calculated and underwent meta-analysis with a random effects model. A summary receiver operating characteristic curve (sROC) was constructed with the Moses-Shapiro-Littenberg method. A chi(2) test was performed to test for heterogeneity (defined as P < .10). Potential sources for heterogeneity were explored by assessing whether certain covariates significantly (P < .05) influenced the relative diagnostic odds ratio. Results: Twenty reports, comprising a total of 849 patients with esophageal cancer, were included. Overall, the studies were of moderate methodologic quality. Sensitivity and specificity of F-18 FDG PET ranged from 33% to 100% and from 30% to 100%, respectively, with pooled estimates of 67% (95% confi dence interval: 62%, 72%) and 68% ( 95% confi dence interval: 64%, 73%), respectively. The area under the sROC curve was 0.7815. There was significant heterogeneity in both the sensitivity and specificity of the included studies (P < .0001). Spearman rho between the logit of sensitivity and the logit of 1-specificity was 0.086 (P = .719), which suggested that there was no threshold effect. Studies performed outside of the United States and studies of higher methodologic quality yielded significantly higher overall accuracy. Conclusion: On the basis of current evidence, 18 F FDG PET should not yet be used in routine clinical practice to guide neoadjuvant therapy decisions in patients with esophageal cancer. (C) RSNA, 2010
引用
收藏
页码:707 / 717
页数:11
相关论文
共 50 条
[31]   [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review [J].
Chowdhury, Fahmid U. ;
Shah, Nehal ;
Scarsbrook, Andrew F. ;
Bradley, Kevin M. .
POSTGRADUATE MEDICAL JOURNAL, 2010, 86 (1013) :174-182
[32]   Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy [J].
Cho, Nariya ;
Im, Seock-Ah ;
Cheon, Gi Jeong ;
Park, In-Ae ;
Lee, Kyung-Hun ;
Kim, Tae-Yong ;
Kim, Young Seon ;
Kwon, Bo Ra ;
Lee, Jung Min ;
Suh, Hoon Young ;
Suh, Koung Jin .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (03) :328-339
[33]   [18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis [J].
Seyed Ali Mirshahvalad ;
Aruz Mesci ;
Vanessa Murad ;
Andres Kohan ;
Claudia Ortega ;
Patrick Veit-Haibach ;
Ur Metser .
European Journal of Nuclear Medicine and Molecular Imaging, 2023, 51 :258-277
[34]   Role of [18F]FDG-PET/CT in Evaluation of Tumor Response to Chemoradiation Therapy for Advanced Colorectal Cancer [J].
Soni, Abhishek ;
Chandola, Stuti ;
Das, Chandan Jyoti ;
Sharma, Raju ;
Pathy, Sushmita ;
Bhattacharjee, Hemanaga Kumar ;
Chandrashekhara, Sheragaru Hanumanthappa ;
Sharma, Atul ;
Kumar, Rakesh .
INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (04) :279-285
[35]   Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with 18F-FDG PET Radiomics Based Machine Learning Classification [J].
Beukinga, Roelof J. ;
Poelmann, Floris B. ;
Kats-Ugurlu, Gursah ;
Viddeleer, Alain R. ;
Boellaard, Ronald ;
De Haas, Robbert J. ;
Plukker, John Th M. ;
Hulshoff, Jan Binne .
DIAGNOSTICS, 2022, 12 (05)
[36]   Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer? [J].
Letizia Deantonio ;
Angela Caroli ;
Erinda Puta ;
Daniela Ferrante ;
Francesco Apicella ;
Lucia Turri ;
Gianmauro Sacchetti ;
Marco Brambilla ;
Marco Krengli .
Radiation Oncology, 13
[37]   Determinants of Response to Neoadjuvant Chemotherapy for Esophageal Cancer Using 18F-fluorodeoxiglucose Positron Emission Tomography (18F-FDG-PET) [J].
Hiroshi Miyata ;
Makoto Yamasaki ;
Tsuyoshi Takahashi ;
Kohei Murakami ;
Koji Tanaka ;
Kurokawa Yukinori ;
Kiyokazu Nakajima ;
Shuji Takiguchi ;
Eiichi Morii ;
Jun Hatazawa ;
Masaki Mori ;
Yuichiro Doki .
Annals of Surgical Oncology, 2014, 21 :575-582
[38]   Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer? [J].
Fagundes, Theara C. ;
Mafra, Arnoldo ;
Silva, Rodrigo G. ;
Castro, Ana C. G. ;
Silva, Luciana C. ;
Aguiar, Priscilla T. ;
Silva, Josiane A. ;
Junior, Eduardo P. ;
Machado, Alexei M. ;
Mamede, Marcelo .
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2018, 64 (02) :119-126
[39]   Tumor Metabolic Phenotypes on 18F FDG PET [J].
Wong, Ching-yee Oliver ;
Khong, Pek-lan .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) :1010-1011
[40]   Outcomes of Patients With Esophageal Cancer Staged With [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET): Can Postchemoradiotherapy FDG-PET Predict the Utility of Resection? [J].
Monjazeb, Arta Monir ;
Riedlinger, Greg ;
Aklilu, Mebea ;
Geisinger, Kim R. ;
Mishra, Girish ;
Isom, Scott ;
Clark, Paige ;
Levine, Edward A. ;
Blackstock, A. William .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (31) :4714-4721